Xeris Biopharma Holdings, Inc. (XERS)
NASDAQ: XERS · Real-Time Price · USD
4.350
-0.070 (-1.58%)
At close: Jun 13, 2025, 4:00 PM
4.330
-0.020 (-0.46%)
After-hours: Jun 13, 2025, 7:30 PM EDT
Xeris Biopharma Holdings Market Cap
Xeris Biopharma Holdings has a market cap or net worth of $696.67 million as of June 13, 2025. Its market cap has increased by 143.48% in one year.
Market Cap
696.67M
Enterprise Value
906.99M
1-Year Change
143.48%
Ranking
Category
Stock Price
$4.35
Market Cap Chart
Since October 6, 2021, Xeris Biopharma Holdings's market cap has increased from $295.78M to $696.67M, an increase of 135.54%. That is a compound annual growth rate of 26.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 13, 2025 | 696.67M | 37.85% |
| Dec 31, 2024 | 505.39M | 55.70% |
| Dec 29, 2023 | 324.59M | 79.47% |
| Dec 30, 2022 | 180.86M | -50.50% |
| Dec 31, 2021 | 365.40M | 23.54% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 731.86B |
| Johnson & Johnson | 374.26B |
| Novo Nordisk | 353.21B |
| AbbVie | 332.69B |
| UnitedHealth Group | 287.73B |
| Abbott Laboratories | 236.27B |
| Novartis AG | 231.84B |
| AstraZeneca | 229.07B |